Chenlu Zhang
180 Fenglin Road
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 22, 2024
LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: February 19, 2024
Lipidomics and Transcriptomics Differ Liposarcoma Differentiation Characteristics That Can Be Altered by Pentose Phosphate Pathway Intervention.
Journal: Metabolites
Published: October 14, 2022
Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma.
Journal: Frontiers in oncology
Published: April 21, 2022
Toripalimab in advanced biliary tract cancer.
Journal: Innovation (Cambridge (Mass.))
Published: January 18, 2022
Twenty-eight months progression-free survival after pyrotinib therapy for HER2-positive recurrent ovarian clear cell carcinoma: a case report.
Journal: Annals of translational medicine
Published: January 18, 2022
Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN.
Journal: Frontiers in oncology
Published: October 26, 2021
Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis.
Journal: Frontiers in molecular biosciences
Published: July 26, 2021
Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing.
Journal: OncoTargets and therapy
Published: July 06, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026